Find clinical trials for Diabetes in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near Warszawa, Mazowieckie, POL:
months (+ 14 days) to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies i...
Warsaw, Poland and 7 other locations
The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...
Phase 3
Warsaw, Poland and 59 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Warsaw, Mazowieckie, Poland and 654 other locations
evaluate the efficacy, safety and pharmacokinetic (PK) properties of CPL207280 after multiple (14 days) administration in patients with type 2 diabetes...
Phase 2
Kajetany, Nadarzyn, Poland
levels when given along with semaglutide in patients with type 2 diabetes. Participants will get the medicine insulin icodec once a week in ...
Phase 3
Warszawa, Mazowieckie, Poland and 32 other locations
as insulin glargine in this form) taken daily in people with type 2 diabetes. The study will look at how well IcoSema controls blood sugar l...
Phase 3
Warszawa, Poland and 90 other locations
This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. Th...
Phase 3
Warszawa, Mazowieckie, Poland and 103 other locations
This study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a n...
Phase 3
Warszawa, Poland and 48 other locations
The study medicine will be investigated in participants with type 2 diabetes. Participants will either get insulin icodec or insulin glargin...
Phase 3
Warszawa, Poland and 69 other locations
help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doct...
Phase 2
Warszawa, Poland and 103 other locations
Clinical trials
Research sites
Resources
Legal